Loading…

Receptor protein tyrosine phosphatases and cancer: New insights from structural biology

There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion...

Full description

Saved in:
Bibliographic Details
Published in:Cell adhesion & migration 2012-07, Vol.6 (4), p.356-364
Main Authors: Nikolaienko, Roman M., Agyekum, Boadi, Bouyain, Samuel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193
container_end_page 364
container_issue 4
container_start_page 356
container_title Cell adhesion & migration
container_volume 6
creator Nikolaienko, Roman M.
Agyekum, Boadi
Bouyain, Samuel
description There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.
doi_str_mv 10.4161/cam.21242
format article
fullrecord <record><control><sourceid>proquest_lande</sourceid><recordid>TN_cdi_landesbioscience_primary_celladhesion_article_21242_10_4161</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1082409773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193</originalsourceid><addsrcrecordid>eNqlkkuLFDEUhYMozji68A9ILXXRY16dVFwIY-MLWoRB1yGV3NiRqqRM0kr_e-PUTOPgQtBVAjnnu-cegtBjgs85EeS5NdM5JZTTO-iUKMZWQlFx93gn_Ql6UMpXjNc9EeI-OqFUKqE4PUXkEizMNeVuzqlCiF095FRChG7epTLvTDUFSmei66yJFvJDdM-bscCj6_MMfX7z-tPm3Wr78e37zcV2ZddC1JVT3nHppeR87bGVXkAvGeZEcq8s8N71hg4tp5LGgmdMDQwII8QNQtKW_Ay9XLjzfpjAWYg1m1HPOUwmH3QyQd9-iWGnv6TvmnHZ03XfAE-vATl920OpegrFwjiaCGlfNME95VhJyZr02SK1bfeSwR_HEKx_Vaxbxfqq4qZ98nuuo_Km0yZ4tQjaIAdlCKnYAK26o_QqhNtBCSlqk2uwIyz0m3kNsv1vyK3QL_4Z18zkL2aKCd1cfMBY4kuiZ-ebhy-eEH3Kk_mR8uh0NYcxZZ_bRwpFsz9z_gTqKuLh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1082409773</pqid></control><display><type>article</type><title>Receptor protein tyrosine phosphatases and cancer: New insights from structural biology</title><source>PubMed Central</source><creator>Nikolaienko, Roman M. ; Agyekum, Boadi ; Bouyain, Samuel</creator><creatorcontrib>Nikolaienko, Roman M. ; Agyekum, Boadi ; Bouyain, Samuel</creatorcontrib><description>There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.</description><identifier>ISSN: 1933-6918</identifier><identifier>EISSN: 1933-6926</identifier><identifier>DOI: 10.4161/cam.21242</identifier><identifier>PMID: 22796942</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Animals ; Binding ; Biology ; Bioscience ; Calcium ; Cancer ; Cell ; cell adhesion ; Cell Communication ; crystal structure ; Cycle ; Gene Expression ; Humans ; inactivating somatic mutations ; Landes ; Models, Molecular ; Mutation ; Neoplasms - enzymology ; Neoplasms - genetics ; Neoplasms - pathology ; oncogene ; Organogenesis ; phosphatase ; phosphorylation ; Protein Interaction Domains and Motifs ; Protein Structure, Quaternary ; Proteins ; receptor overexpression ; receptor protein tyrosine phosphatase ; Receptor-Like Protein Tyrosine Phosphatases - chemistry ; Receptor-Like Protein Tyrosine Phosphatases - genetics ; Receptor-Like Protein Tyrosine Phosphatases - metabolism ; Review ; tumor suppressor</subject><ispartof>Cell adhesion &amp; migration, 2012-07, Vol.6 (4), p.356-364</ispartof><rights>Copyright © 2012 Landes Bioscience 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478258/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478258/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22796942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nikolaienko, Roman M.</creatorcontrib><creatorcontrib>Agyekum, Boadi</creatorcontrib><creatorcontrib>Bouyain, Samuel</creatorcontrib><title>Receptor protein tyrosine phosphatases and cancer: New insights from structural biology</title><title>Cell adhesion &amp; migration</title><addtitle>Cell Adh Migr</addtitle><description>There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.</description><subject>Animals</subject><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>cell adhesion</subject><subject>Cell Communication</subject><subject>crystal structure</subject><subject>Cycle</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>inactivating somatic mutations</subject><subject>Landes</subject><subject>Models, Molecular</subject><subject>Mutation</subject><subject>Neoplasms - enzymology</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>oncogene</subject><subject>Organogenesis</subject><subject>phosphatase</subject><subject>phosphorylation</subject><subject>Protein Interaction Domains and Motifs</subject><subject>Protein Structure, Quaternary</subject><subject>Proteins</subject><subject>receptor overexpression</subject><subject>receptor protein tyrosine phosphatase</subject><subject>Receptor-Like Protein Tyrosine Phosphatases - chemistry</subject><subject>Receptor-Like Protein Tyrosine Phosphatases - genetics</subject><subject>Receptor-Like Protein Tyrosine Phosphatases - metabolism</subject><subject>Review</subject><subject>tumor suppressor</subject><issn>1933-6918</issn><issn>1933-6926</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqlkkuLFDEUhYMozji68A9ILXXRY16dVFwIY-MLWoRB1yGV3NiRqqRM0kr_e-PUTOPgQtBVAjnnu-cegtBjgs85EeS5NdM5JZTTO-iUKMZWQlFx93gn_Ql6UMpXjNc9EeI-OqFUKqE4PUXkEizMNeVuzqlCiF095FRChG7epTLvTDUFSmei66yJFvJDdM-bscCj6_MMfX7z-tPm3Wr78e37zcV2ZddC1JVT3nHppeR87bGVXkAvGeZEcq8s8N71hg4tp5LGgmdMDQwII8QNQtKW_Ay9XLjzfpjAWYg1m1HPOUwmH3QyQd9-iWGnv6TvmnHZ03XfAE-vATl920OpegrFwjiaCGlfNME95VhJyZr02SK1bfeSwR_HEKx_Vaxbxfqq4qZ98nuuo_Km0yZ4tQjaIAdlCKnYAK26o_QqhNtBCSlqk2uwIyz0m3kNsv1vyK3QL_4Z18zkL2aKCd1cfMBY4kuiZ-ebhy-eEH3Kk_mR8uh0NYcxZZ_bRwpFsz9z_gTqKuLh</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Nikolaienko, Roman M.</creator><creator>Agyekum, Boadi</creator><creator>Bouyain, Samuel</creator><general>Taylor &amp; Francis</general><general>Landes Bioscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120701</creationdate><title>Receptor protein tyrosine phosphatases and cancer</title><author>Nikolaienko, Roman M. ; Agyekum, Boadi ; Bouyain, Samuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>cell adhesion</topic><topic>Cell Communication</topic><topic>crystal structure</topic><topic>Cycle</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>inactivating somatic mutations</topic><topic>Landes</topic><topic>Models, Molecular</topic><topic>Mutation</topic><topic>Neoplasms - enzymology</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>oncogene</topic><topic>Organogenesis</topic><topic>phosphatase</topic><topic>phosphorylation</topic><topic>Protein Interaction Domains and Motifs</topic><topic>Protein Structure, Quaternary</topic><topic>Proteins</topic><topic>receptor overexpression</topic><topic>receptor protein tyrosine phosphatase</topic><topic>Receptor-Like Protein Tyrosine Phosphatases - chemistry</topic><topic>Receptor-Like Protein Tyrosine Phosphatases - genetics</topic><topic>Receptor-Like Protein Tyrosine Phosphatases - metabolism</topic><topic>Review</topic><topic>tumor suppressor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nikolaienko, Roman M.</creatorcontrib><creatorcontrib>Agyekum, Boadi</creatorcontrib><creatorcontrib>Bouyain, Samuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell adhesion &amp; migration</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nikolaienko, Roman M.</au><au>Agyekum, Boadi</au><au>Bouyain, Samuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Receptor protein tyrosine phosphatases and cancer: New insights from structural biology</atitle><jtitle>Cell adhesion &amp; migration</jtitle><addtitle>Cell Adh Migr</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>6</volume><issue>4</issue><spage>356</spage><epage>364</epage><pages>356-364</pages><issn>1933-6918</issn><eissn>1933-6926</eissn><abstract>There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>22796942</pmid><doi>10.4161/cam.21242</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1933-6918
ispartof Cell adhesion & migration, 2012-07, Vol.6 (4), p.356-364
issn 1933-6918
1933-6926
language eng
recordid cdi_landesbioscience_primary_celladhesion_article_21242_10_4161
source PubMed Central
subjects Animals
Binding
Biology
Bioscience
Calcium
Cancer
Cell
cell adhesion
Cell Communication
crystal structure
Cycle
Gene Expression
Humans
inactivating somatic mutations
Landes
Models, Molecular
Mutation
Neoplasms - enzymology
Neoplasms - genetics
Neoplasms - pathology
oncogene
Organogenesis
phosphatase
phosphorylation
Protein Interaction Domains and Motifs
Protein Structure, Quaternary
Proteins
receptor overexpression
receptor protein tyrosine phosphatase
Receptor-Like Protein Tyrosine Phosphatases - chemistry
Receptor-Like Protein Tyrosine Phosphatases - genetics
Receptor-Like Protein Tyrosine Phosphatases - metabolism
Review
tumor suppressor
title Receptor protein tyrosine phosphatases and cancer: New insights from structural biology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A52%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_lande&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Receptor%20protein%20tyrosine%20phosphatases%20and%20cancer:%20New%20insights%20from%20structural%20biology&rft.jtitle=Cell%20adhesion%20&%20migration&rft.au=Nikolaienko,%20Roman%20M.&rft.date=2012-07-01&rft.volume=6&rft.issue=4&rft.spage=356&rft.epage=364&rft.pages=356-364&rft.issn=1933-6918&rft.eissn=1933-6926&rft_id=info:doi/10.4161/cam.21242&rft_dat=%3Cproquest_lande%3E1082409773%3C/proquest_lande%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1082409773&rft_id=info:pmid/22796942&rfr_iscdi=true